On May 14, 2008 the House of Representative's Committee on Oversight and Government Reform will convene a hearing to explore the legal doctrine of federal preemption in the context of product liability lawsuits involving FDA-approved drugs and medical devices.
Discuss Add this link to...Bury Add to:
| Bookmarks
Comments